Reported 11 months ago
Zhongen Biotech, focusing on rare disease cell new drug development, attended the 'INTERPHEX Week Tokyo' exhibition in Japan where they announced further collaboration with Shibuya to expand cooperation in the field of cell therapy and regenerative medicine. By introducing advanced automated equipment and technology from Japan's Shibuya, as well as advanced cell culture platforms and automated production lines, Zhongen Biotech aims to significantly increase production efficiency and product quality while reducing the risk of human error. The collaboration is expected to enhance international market competitiveness and bring more advanced and efficient treatment solutions to global patients.
Source: YAHOO